Market
GE HealthCare’s stock plunges 13% as supply chain costs bite
GE HealthCare lowered its 2026 growth forecast, citing rising freight costs and material expenses. The revision, a 3.3 percentage-point reduction at the top end of guidance, prompted a 13% stock decline. The move reflects broader supply chain pressures affecting the medical device manufacturer's outlook.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network